Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry

Abstract Background and objective Gastroesophageal reflux disease (GORD) is highly prevalent in idiopathic pulmonary fibrosis (IPF) and may play a role in its pathogenesis. Recent IPF treatment guidelines suggest that all patients with IPF be considered for antacid therapy. However, emerging evidenc...

Full description

Bibliographic Details
Main Authors: Helen E. Jo, Tamera J. Corte, Ian Glaspole, Christopher Grainge, Peter M. A. Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Christopher Zappala, Heather Allan, Gregory J. Keir, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Sacha Macansh, Nicole S. Goh
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Pulmonary Medicine
Subjects:
Idiopathic pulmonary fibrosis
Gastroesophageal reflux disease
Antacid
Registry
Cough
Online Access:http://link.springer.com/article/10.1186/s12890-019-0846-2

Internet

http://link.springer.com/article/10.1186/s12890-019-0846-2

Similar Items